The Joint Commission Achieves Deeming Authority from CMS for Accreditation

July 1, 2024
The Joint Commission can now accredit organizations in certain fields for a six year period, which is the maximum term of approval granted by CMS.

The Joint Commission has achieved “renewed deeming authority from the U.S. Centers for Medicare & Medicaid Services (CMS) for its Laboratory and Point-of-Care Testing Accreditation Program, effective May 24, 2024 through May 24, 2030. Six years is the maximum term of approval granted by CMS.”

The Joint Commission “was recognized by CMS for fulfilling all necessary requirements under the CLIA program. CLIA regulations require that all laboratories be surveyed on a two-year cycle during an on-site survey or inspection by an approved AO [accrediting organization] for all non-waived tests of moderate or high complexity.” It is a CMS-approved AO, meaning it can accredit clinical laboratories wishing to obtain Medicare reimbursement.

The Joint Commission was specifically approved to accredit organizations in microbiology, diagnostic immunology, chemistry, hematology, immunohematology, and pathology.

About the Author

Matt MacKenzie | Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

Photo 100961553 © Mohamed Ahmed Soliman | Dreamstime.com
Photo 63686453 © Convisum | Dreamstime.com
Photo 112500600 © Ken Wolter | Dreamstime.com
Photo 171785729 © Mark Gomez | Dreamstime.com